05-Nov-2026 22:23:39
JUBLPHARMAGeneral news
JUBLPHARMA : RAISES RS 800 CR VIA NCD PRIVATE PLACEMENT
• Finance Committee approved allotment of 80,000 unsecured, rated, listed, redeemable NCDs of face value ₹1,00,000 each at par • Issue aggregates to ₹800 Cr on private placement basis to successful bidders • Tenure 3 years; allotted November 5, 2026, maturing November 5, 2028 • Coupon offered at 8.50% p.a. • Debentures to be listed on BSE; no charge or security created over assets Impact: Neutral (₹800 Cr unsecured debt at 8.50% adds funding flexibility but raises interest outgo)
Jubilant Pharmova Ltd
Open attachment